The top 10 biopharma stock gainers and losers for the week.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2025.

Year-to-date money raised in public, private and other financings of biopharma companies.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Atossa, BMS, Innocare, Kymera, Praxis, Sanofi, Serina.

Biopharma happenings, including deals and partnerships, and other news in brief: Basilea, Geron, Nanology, Phare.

Clinical updates, including data readouts and publications: Beyondspring, Carrick, Corbus, Elicio, Genoscience, GRI, Immatics, Immunewalk, Novabridge, Okyo, Rhythm, Valneva.

Biopharmas raising money in public or private financings, including: Allegria, Apimeds, Aukera, Citius, Faron, GRI, Hemostemix, Immunovant, Prolynx, Roivant.

New hires and promotions in the biopharma industry, including: Azafaros, Geovax, Kyowa, Neurenati, Nuvalent, Prolynx.

New hires and promotions in the med-tech industry, including: Advamed.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Exact Sciences, Roivios.